Cargando…
Assessment of the Neuroprotective and Stemness Properties of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells under Variable (5% vs. 21%) Aerobic Conditions
To optimise the culture conditions for human Wharton’s jelly-derived mesenchymal stem cells (hWJ-MSCs) intended for clinical use, we investigated ten different properties of these cells cultured under 21% (atmospheric) and 5% (physiological normoxia) oxygen concentrations. The obtained results indic...
Autores principales: | Tomecka, Ewelina, Lech, Wioletta, Zychowicz, Marzena, Sarnowska, Anna, Murzyn, Magdalena, Oldak, Tomasz, Domanska-Janik, Krystyna, Buzanska, Leonora, Rozwadowska, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063843/ https://www.ncbi.nlm.nih.gov/pubmed/33804841 http://dx.doi.org/10.3390/cells10040717 |
Ejemplares similares
-
Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton's Jelly (WJ-MSCs)
por: Lech, Wioletta, et al.
Publicado: (2020) -
Neuroprotective Potential and Paracrine Activity of Stromal Vs. Culture-Expanded hMSC Derived from Wharton Jelly under Co-Cultured with Hippocampal Organotypic Slices
por: Dabrowska, Sylwia, et al.
Publicado: (2017) -
Phenotypic, Functional, and Safety Control at Preimplantation Phase of MSC-Based Therapy
por: Lech, Wioletta, et al.
Publicado: (2016) -
Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly
por: Sypecka, Monika, et al.
Publicado: (2022) -
Safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
por: Barczewska, Monika, et al.
Publicado: (2019)